Analysis of patients with extrahepatic cholangiocarcinoma showed that alterations in TP53 and ATM were the two most common in ctDNA (Figure 4A), whereas KRAS was the most common, followed by APC and ATM, in corresponding tumor tissue (Figure 4B). This evidence concerns the gene KRAS and neoplasm.